Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
09/2003
09/10/2003CN1440758A Bioactive hill wasp powder and its prepn
09/10/2003CN1440757A Bioactive Chinese woodfrog oil lecithin powder and its prepn
09/10/2003CN1440750A Delayed releasing kurarinol prepn
09/10/2003CN1440744A Coated nano melatonin composite health tonic
09/10/2003CN1120718C Compound indigofera pseudotinetoria medicine for treating chronic heptofibrosis
09/10/2003CN1120715C Chinese medicine for treating fatty liver
09/10/2003CN1120712C Chinese medicine for reducing cholesterol, biliary calcules and bile viscosity
09/10/2003CN1120711C Detoxication tea for cleaning intestine
09/10/2003CN1120707C Ligands to enhance cellular uptake of biomolecules
09/09/2003US6617359 4-fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical
09/09/2003US6617338 Condensation of omeprazole, lansoprazole or pantoprazole with an addition copolymer having acrylonitrile, acrylic ester or aromatic olefin monomers, to form the polymer conjugate; improved bioavailability
09/09/2003US6617336 Treatment of urinary incontinence, venous insufficiency, migraine or gastrointestinal disorders
09/09/2003US6617325 Biphenyl derivatives, production thereof and uses as medicines
09/09/2003US6617324 Substituted pyrazoles as p38 kinase inhibitors
09/09/2003US6617322 Administering a piperazine or piperidine coupled through a linker to a benzhydril
09/09/2003US6616938 Method of making chewing gum containing colloidal bismuth subcitrate
09/09/2003CA2263566C Substituted 6,5-hetero-bicyclic derivatives
09/09/2003CA2087298C Bile acid sulfurated derivatives
09/09/2003CA2037114C N-cycloalkylalkylamines, their process of preparation, their use as medication and their synthetic intermediates
09/09/2003CA2031480C Acetylenes disubstituted with a heteroaromatic group and a substituted phenyl group having retinoid like activity
09/04/2003WO2003073107A2 Neuropeptide receptor and uses thereof
09/04/2003WO2003073099A1 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome
09/04/2003WO2003072780A1 Novel proteins, dnas thereof and use of the same
09/04/2003WO2003072711A2 Method of using modified oligonucleotides for hepatic delivery
09/04/2003WO2003072704A2 RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/04/2003WO2003072572A1 Beta3-adrenergic receptor agonists
09/04/2003WO2003072569A1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
09/04/2003WO2003072558A2 Arylsulfone derivatives
09/04/2003WO2003072557A1 5-phenylthiazole derivatives and use as pi3 kinase inhibitors
09/04/2003WO2003072550A1 Novel fused ring indazole compounds
09/04/2003WO2003072545A1 Cyclic amine compound and ccr3 inhibitory drug containing the same as active ingredient
09/04/2003WO2003072544A1 Crystalline anhydrous and monohydrate benzoate salts of (2's,3s)-3-hydroxy-n-{2{n-methyl-n-4-(n-propylamino-carbonyl)phenyl]amino-2-phenyl}-ethylpyrrolidine
09/04/2003WO2003072539A1 Phenethanolamine derivatives for treatment of respiratory diseases
09/04/2003WO2003072196A1 Lower esophagus tissue modifier
09/04/2003WO2003072195A2 Method for administering glp-1 molecules
09/04/2003WO2003072159A1 N-{5-[4-(4-methyl-piperazino-methyl)­-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents
09/04/2003WO2003072135A2 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
09/04/2003WO2003072123A1 Stabilized albumin preparaions
09/04/2003WO2003072110A1 Use of biogenic estriol diester prodrugs for the treatment of autoimmune diseases
09/04/2003WO2003072109A1 Use of biogenic estriol sulfamate prodrugs for the treatment of autoimmune diseases
09/04/2003WO2003072107A1 Substituted pyrimidinones and pyrimidinthiones
09/04/2003WO2003072095A1 Sofalcone-containing compositions
09/04/2003WO2003072094A1 Ambroxol for treating painful conditions in the mouth and pharyngeal cavity
09/04/2003WO2003072067A2 Compositions and methods for treating epithelial and retinal tissue diseases
09/04/2003WO2003072061A2 Methods and compositions for treating gastrointestinal toxicity induced by cytoablative therapy
09/04/2003WO2003072060A2 Polypeptide formulation
09/04/2003WO2003072056A2 Intranasal administration of mc4-r agonists
09/04/2003WO2003072048A2 Symptomatic relief of gastrointestinal disorders
09/04/2003WO2003072040A2 Administration of agents for the treatment of inflammation
09/04/2003WO2003072035A2 Compositions and methods for the treatment of immune related diseases
09/04/2003WO2003072027A2 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof
09/04/2003WO2003072022A2 Oral trimethobenzamide formulations and methods
09/04/2003WO2003072021A2 Oral pediatric trimethobenzamide formulations and methods
09/04/2003WO2003072012A2 Oral dna composition for hepatitis b virus chronic infection
09/04/2003WO2003064472A3 Treatment of ms with goat serum
09/04/2003WO2003063840A3 Transmucosal delivery of proton pump inhibitors
09/04/2003WO2003062209A3 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
09/04/2003WO2003051805A3 Substituted phenyl naphthalenes as estrogenic agents
09/04/2003WO2003050053A3 Use of an antimicrobial glass ceramic for dental care and oral hygiene
09/04/2003WO2003045313A3 2-aminoquinoline compounds
09/04/2003WO2003035646A3 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist
09/04/2003WO2003033681A3 Composition comprising a lactobacillus pentosus strain and uses thereof
09/04/2003WO2003030922A3 Bestrophin and bestrophin homologous proteins involved in the regulation of energy homeostasis
09/04/2003WO2003011860A3 2-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-N-[6-(1,1-DIOXO-1λ6-THIOMORPHOLIN-4-YL)-4-(2-METHYL OR 4-FLUORO-2-METHYL SUBSTITUTED)PHENYL-PYRIDIN-3-YL]-N-METHYL-ISOBUTYRAMIDE
09/04/2003WO2002101069A3 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
09/04/2003WO2002088106A3 Cysteine protease inhibitors
09/04/2003WO2002079248A3 Mammalian alpha-helical protein-53
09/04/2003WO2002079238A3 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis
09/04/2003WO2002070468A3 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity
09/04/2003WO2002064792A3 Molecules for disease detection and treatment
09/04/2003WO2002055698A3 Transcriptional mediators of blood vessel development and endothelial differentiation
09/04/2003WO2002055016A3 INHIBITION OF NF-λB BY TRITERPENE COMPOSITIONS
09/04/2003WO2002046426A3 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor
09/04/2003WO2002032932A3 Urotensin-ii agonists and antagonists
09/04/2003WO2002015892A3 Combination comprising an insulin secretion enhancer and an active ingredient selected from hmg-co-a reductase inhibitors and ace inhibitors
09/04/2003WO2001085193A3 Method for promoting neovascularization using a tweak agonist and an angiogenic factor
09/04/2003WO2001057261A9 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
09/04/2003US20030166945 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
09/04/2003US20030166935 Spiroazabicyclic heterocyclic compounds
09/04/2003US20030166928 Central nervous system disorders, sleep disorders, eating disorders. sexual disorders, hypotensive agents
09/04/2003US20030166927 1,5-Benzothiazepines and their use as hypolipidaemics
09/04/2003US20030166911 Hybrid nucleic acids; genetic engineering
09/04/2003US20030166899 Antiinflammatory agents; antiarthritic agents; anticancer agents
09/04/2003US20030166730 Amide derivatives for the treatment of diseases mediated by cytokines
09/04/2003US20030166723 Gamma-linolenic acid, di-homo-gamma-linolenic acid and derivatives
09/04/2003US20030166718 Dry powder granulated formulation of the compound racedotril useful for treating diarrhea
09/04/2003US20030166708 Cyclic substituted aminomethyl compounds and medicaments comprising these compounds
09/04/2003US20030166701 Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
09/04/2003US20030166690 Use of compounds for decreasing activity of hormone-sensitive
09/04/2003US20030166687 Alpha-hydroxy,-amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors
09/04/2003US20030166685 Acid derivatives of benzene useful as anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer
09/04/2003US20030166680 For treating serine protease or dual-serine protease mediated disorders
09/04/2003US20030166671 Amorphous polymorphic forms by grinding or pulverizing; having a distinctive X-ray powder diffraction pattern; anti-tumor and -carcinogenic agents; administered by mouth, intravenous injection and inhalation
09/04/2003US20030166653 Novel form of (r)-n-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide
09/04/2003US20030166652 Chemical compounds
09/04/2003US20030166650 E.g., 3-(2-fluorophenyl)-N-(1-(3-morpholin-4-yl)phenyl)-propyl)acrylamide; disorders responsive to opening of KCNQ potassium channels; analgesics; migraine, bipolar disorders, anticonvulsants, antiepileptic, anxiolytic agents
09/04/2003US20030166646 Nitric oxide synthase inhibitors such as 4-(morpholin-4-yl methyl)-4,5-dihydro-1,3-thiazol-2-ylamine, administered for prophylaxis of neurodegenerative diseases
09/04/2003US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/04/2003US20030166634 Amines such as 3,3,5,5-Tetramethyl-1-vinylcyclohexanamine hydrochloride, used as N-methyl-D-aspartate (NMDA), serotonin and nicotinic acetylcholine receptor antagonists
09/04/2003US20030166633 Pyridinylimidazoles
1 ... 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 ... 1258